A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia

Detalles Bibliográficos
Autores principales: Uy, G L, Rettig, M P, Stone, R M, Konopleva, M Y, Andreeff, M, McFarland, K, Shannon, W, Fletcher, T R, Reineck, T, Eades, W, Stockerl-Goldstein, K, Abboud, C N, Jacoby, M A, Westervelt, P, DiPersio, J F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380905/
https://www.ncbi.nlm.nih.gov/pubmed/28282031
http://dx.doi.org/10.1038/bcj.2017.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380905/
https://www.ncbi.nlm.nih.gov/pubmed/28282031
http://dx.doi.org/10.1038/bcj.2017.21

Ejemplares similares